BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nucci MR, Harburger D, Koontz J, Cin PD, Sklar J. Molecular Analysis of the JAZF1-JJAZ1 Gene Fusion by RT-PCR and Fluorescence In Situ Hybridization in Endometrial Stromal Neoplasms. American Journal of Surgical Pathology 2007;31:65-70. [DOI: 10.1097/01.pas.0000213327.86992.d1] [Cited by in Crossref: 108] [Cited by in F6Publishing: 110] [Article Influence: 7.2] [Reference Citation Analysis]
Number Citing Articles
1 Nucci MR, Webster F, Croce S, George S, Howitt BE, Ip PP, Lee C, Rabban JT, Soslow RA, van der Griend R, Lax SF, Mccluggage WG. Data Set for Reporting of Uterine Malignant and Potentially Malignant Mesenchymal Tumors: Recommendations From the International Collaboration on Cancer Reporting (ICCR). International Journal of Gynecological Pathology 2022;41:S44-S63. [DOI: 10.1097/pgp.0000000000000911] [Reference Citation Analysis]
2 Küpker W, Aizpurua J, Felberbaum RE, Bullerdiek J. Molekulare Pathologie benigner gynäkologischer Erkrankungen – ist sie hilfreich bei zukünftigen Therapieentscheidungen? Gynäkologie 2022;55:409-414. [DOI: 10.1007/s00129-022-04951-4] [Reference Citation Analysis]
3 Pitolli C, Marini A, Sette C, Pagliarini V. Non-Canonical Splicing and Its Implications in Brain Physiology and Cancer. IJMS 2022;23:2811. [DOI: 10.3390/ijms23052811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Chiang S, Vasudevaraja V, Serrano J, Stewart CJR, Oliva E, Momeni-Boroujeni A, Jungbluth AA, Da Cruz Paula A, da Silva EM, Weigelt B, Park KJ, Soslow RA, Murali R, Ellenson LH, Benayed R, Ladanyi M, Abu-Rustum NR, Dickson MA, Cohen S, Aghajanian C, Hensley ML, Lee CH, Snuderl M, Konner JA. TSC2-mutant uterine sarcomas with JAZF1-SUZ12 fusions demonstrate hybrid features of endometrial stromal sarcoma and PEComa and are responsive to mTOR inhibition. Mod Pathol 2021. [PMID: 34561551 DOI: 10.1038/s41379-021-00922-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
5 Akaev I, Yeoh CC, Rahimi S. Update on Endometrial Stromal Tumours of the Uterus. Diagnostics (Basel) 2021;11:429. [PMID: 33802452 DOI: 10.3390/diagnostics11030429] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
6 Adefuye P, Olawaiye A. Cancer of the Uterine Corpus. Contemporary Obstetrics and Gynecology for Developing Countries 2021. [DOI: 10.1007/978-3-030-75385-6_57] [Reference Citation Analysis]
7 Zhang H, Hicks DG. Breast and Gynecologic Tumors. Practical Oncologic Molecular Pathology 2021. [DOI: 10.1007/978-3-030-73227-1_5] [Reference Citation Analysis]
8 Micci F, Heim S, Panagopoulos I. Molecular pathogenesis and prognostication of "low-grade'' and "high-grade" endometrial stromal sarcoma. Genes Chromosomes Cancer 2021;60:160-7. [PMID: 33099834 DOI: 10.1002/gcc.22907] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
9 Nomura Y, Tamura D, Horie M, Sato M, Sasaki S, Yamamoto Y, Kudo-Asabe Y, Umakoshi M, Koyama K, Makino K, Takashima S, Imai K, Minamiya Y, Munakata S, Yachida S, Terada Y, Goto A, Maeda D. Detection of MEAF6-PHF1 translocation in an endometrial stromal nodule. Genes Chromosomes Cancer 2020. [PMID: 32820570 DOI: 10.1002/gcc.22892] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
10 Hirsch MS, Watkins J. A Comprehensive Review of Biomarker Use in the Gynecologic Tract Including Differential Diagnoses and Diagnostic Pitfalls. Adv Anat Pathol 2020;27:164-92. [PMID: 31149908 DOI: 10.1097/PAP.0000000000000238] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
11 Hensley ML, Chavan SS, Solit DB, Murali R, Soslow R, Chiang S, Jungbluth AA, Bandlamudi C, Srinivasan P, Tap WD, Rosenbaum E, Taylor BS, Donoghue MTA, Hyman DM. Genomic Landscape of Uterine Sarcomas Defined Through Prospective Clinical Sequencing. Clin Cancer Res 2020;26:3881-8. [PMID: 32299819 DOI: 10.1158/1078-0432.CCR-19-3959] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 15.5] [Reference Citation Analysis]
12 Parra-herran C. Mesenchymal and Miscellaneous Lesions of the Uterus. Gynecologic Pathology 2020. [DOI: 10.1016/b978-0-323-35909-2.00011-4] [Reference Citation Analysis]
13 Dillon JL, Tafe LJ. Gynecologic Malignancies. Genomic Medicine 2020. [DOI: 10.1007/978-3-030-22922-1_10] [Reference Citation Analysis]
14 Parra-Herran C, Howitt BE. Uterine Mesenchymal Tumors: Update on Classification, Staging, and Molecular Features. Surg Pathol Clin 2019;12:363-96. [PMID: 31097109 DOI: 10.1016/j.path.2019.01.004] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
15 Chwalenia K, Qin F, Singh S, Li H. A cell-based splicing reporter system to identify regulators of cis-splicing between adjacent genes. Nucleic Acids Res 2019;47:e24. [PMID: 30590765 DOI: 10.1093/nar/gky1288] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
16 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. In: Kurman RJ, Hedrick Ellenson L, Ronnett BM, editors. Blaustein's Pathology of the Female Genital Tract. Cham: Springer International Publishing; 2019. pp. 535-647. [DOI: 10.1007/978-3-319-46334-6_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
17 McCarthy AJ, Clarke BA, McGilvray I, Dickson BC, Khalili K, Chetty R. Metastatic low-grade endometrial stromal sarcoma of uterus presenting as a primary pancreatic tumor: case presentation and literature review. Diagn Pathol 2019;14:30. [PMID: 31010432 DOI: 10.1186/s13000-019-0807-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Micci F, Davidson B. Molecular Genetics of Uterine Sarcomas. eLS 2019. [DOI: 10.1002/9780470015902.a0028464] [Reference Citation Analysis]
19 Meurer M, Floquet A, Ray-Coquard I, Bertucci F, Auriche M, Cordoba A, Piperno-Neumann S, Salas S, Delannes M, Chevalier T, Italiano A, Blay JY, Mancini J, Pautier P, Duffaud F. Localized high grade endometrial stromal sarcoma and localized undifferentiated uterine sarcoma: a retrospective series of the French Sarcoma Group. Int J Gynecol Cancer. 2019;29:691-698. [PMID: 30772825 DOI: 10.1136/ijgc-2018-000064] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
20 Dickson BC. Beyond Smooth Muscle-Other Mesenchymal Neoplasms of the Uterus. Surg Pathol Clin 2019;12:107-37. [PMID: 30709439 DOI: 10.1016/j.path.2018.10.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
21 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2019. [DOI: 10.1007/978-3-319-96830-8_31] [Reference Citation Analysis]
22 Wang W, Lazar AJ. Applications of Molecular Testing to Differential Diagnosis. Practical Soft Tissue Pathology: a Diagnostic Approach 2019. [DOI: 10.1016/b978-0-323-49714-5.00018-1] [Reference Citation Analysis]
23 Howitt BE, Nucci MR. Uterine Mesenchymal Lesions. Gynecologic and Obstetric Pathology, Volume 2 2019. [DOI: 10.1007/978-981-13-3019-3_1] [Reference Citation Analysis]
24 Murdock TA, Veras EFT, Kurman RJ, Mazur MT. Mesenchymal Tumors and Other Rare Neoplasms. Diagnosis of Endometrial Biopsies and Curettings 2019. [DOI: 10.1007/978-3-319-98608-1_11] [Reference Citation Analysis]
25 Mbatani N, Olawaiye AB, Prat J. Uterine sarcomas. Int J Gynaecol Obstet. 2018;143 Suppl 2:51-58. [PMID: 30306577 DOI: 10.1002/ijgo.12613] [Cited by in Crossref: 62] [Cited by in F6Publishing: 66] [Article Influence: 15.5] [Reference Citation Analysis]
26 Ferreira J, Félix A, Lennerz JK, Oliva E. Recent advances in the histological and molecular classification of endometrial stromal neoplasms. Virchows Arch 2018;473:665-78. [DOI: 10.1007/s00428-018-2470-6] [Cited by in Crossref: 35] [Cited by in F6Publishing: 27] [Article Influence: 8.8] [Reference Citation Analysis]
27 Zappacosta R, Fanfani F, Zappacosta B, Sablone F, Pansa L, Liberati M, Rosini S. Uterine Sarcomas: An Updated Overview. Neoplasm 2018. [DOI: 10.5772/intechopen.78980] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Tuyaerts S, Amant F. Endometrial Stromal Sarcomas: A Revision of Their Potential as Targets for Immunotherapy. Vaccines (Basel) 2018;6:E56. [PMID: 30149610 DOI: 10.3390/vaccines6030056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
29 Dickson BC, Lum A, Swanson D, Bernardini MQ, Colgan TJ, Shaw PA, Yip S, Lee CH. Novel EPC1 gene fusions in endometrial stromal sarcoma. Genes Chromosomes Cancer 2018;57:598-603. [PMID: 30144186 DOI: 10.1002/gcc.22649] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
30 Gupta R, Cooper WA, Selinger C, Mahar A, Anderson L, Buckland ME, O'Toole SA. Fluorescent In Situ Hybridization in Surgical Pathology Practice. Adv Anat Pathol 2018;25:223-37. [PMID: 29727321 DOI: 10.1097/PAP.0000000000000194] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
31 Billingsley CC, Eisenhauer EL. Uterine Sarcoma. Gynecologic Care 2018. [DOI: 10.1017/9781108178594.034] [Reference Citation Analysis]
32 Köhler G, Zygmunt MT. Uterine Sarcomas and Atypical Smooth-Muscle Tumors: Clinic, Diagnostics and Appropriate Surgical Therapy. Hysterectomy 2018. [DOI: 10.1007/978-3-319-22497-8_14] [Reference Citation Analysis]
33 Oliva E, Zaloudek CJ, Soslow RA. Mesenchymal Tumors of the Uterus. Blaustein's Pathology of the Female Genital Tract 2018. [DOI: 10.1007/978-1-4614-3165-7_10-2] [Reference Citation Analysis]
34 Howitt BE, Nucci MR, Quade BJ. Uterine Mesenchymal Tumors. Diagnostic Gynecologic and Obstetric Pathology 2018. [DOI: 10.1016/b978-0-323-44732-4.00020-0] [Reference Citation Analysis]
35 Wojcik J, Cooper K. Epigenetic Alterations in Bone and Soft Tissue Tumors. Adv Anat Pathol 2017;24:362-71. [PMID: 28885261 DOI: 10.1097/PAP.0000000000000167] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
36 Wang L, Cui Y, Sheng J, Yang Y, Kuang G, Fan Y, Jin J, Zhang Q. Epigenetic inactivation of HOXA11, a novel functional tumor suppressor for renal cell carcinoma, is associated with RCC TNM classification. Oncotarget 2017;8:21861-70. [PMID: 28423531 DOI: 10.18632/oncotarget.15668] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
37 Ritterhouse LL, Howitt BE. Molecular Pathology: Predictive, Prognostic, and Diagnostic Markers in Uterine Tumors. Surg Pathol Clin 2016;9:405-26. [PMID: 27523969 DOI: 10.1016/j.path.2016.04.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.6] [Reference Citation Analysis]
38 Hoang LN, Aneja A, Conlon N, Delair DF, Middha S, Benayed R, Hensley ML, Park KJ, Hollmann TJ, Hameed MR, Antonescu CR, Soslow RA, Chiang S. Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma. Am J Surg Pathol 2017;41:12-24. [PMID: 27631520 DOI: 10.1097/PAS.0000000000000721] [Cited by in Crossref: 84] [Cited by in F6Publishing: 90] [Article Influence: 16.8] [Reference Citation Analysis]
39 Howitt BE, Nucci MR. Molecular Pathology of Uterine Mesenchymal Tumors. Molecular Pathology Library 2017. [DOI: 10.1007/978-3-319-57985-6_11] [Reference Citation Analysis]
40 Wassef M, Margueron R. The Multiple Facets of PRC2 Alterations in Cancers. J Mol Biol 2017;429:1978-93. [PMID: 27742591 DOI: 10.1016/j.jmb.2016.10.012] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 5.7] [Reference Citation Analysis]
41 Rommel B, Holzmann C, Bullerdiek J. Malignant mesenchymal tumors of the uterus - time to advocate a genetic classification. Expert Rev Anticancer Ther 2016;16:1155-66. [PMID: 27602604 DOI: 10.1080/14737140.2016.1233817] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
42 Choi YJ, Jung SH, Kim MS, Baek IP, Rhee JK, Lee SH, Hur SY, Kim TM, Chung YJ, Lee SH. Genomic landscape of endometrial stromal sarcoma of uterus. Oncotarget 2015;6:33319-28. [PMID: 26429873 DOI: 10.18632/oncotarget.5384] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.8] [Reference Citation Analysis]
43 Prat J, Mbatani N. Uterine sarcomas. Int J Gynaecol Obstet. 2015;131 Suppl 2:S105-S110. [PMID: 26433666 DOI: 10.1016/j.ijgo.2015.06.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
44 Hrzenjak A. JAZF1/SUZ12 gene fusion in endometrial stromal sarcomas. Orphanet J Rare Dis 2016;11:15. [PMID: 26879382 DOI: 10.1186/s13023-016-0400-8] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 6.3] [Reference Citation Analysis]
45 Zhang Q, Wei J. Putative Precursors of Uterine Sarcomas. Precancerous Lesions of the Gynecologic Tract 2016. [DOI: 10.1007/978-3-319-22509-8_6] [Reference Citation Analysis]
46 Brennan MF, Antonescu CR, Alektiar KM, Maki RG. Other Uterine Sarcomas. Management of Soft Tissue Sarcoma 2016. [DOI: 10.1007/978-3-319-41906-0_21] [Reference Citation Analysis]
47 Nucci MR. Practical issues related to uterine pathology: endometrial stromal tumors. Mod Pathol 2016;29:S92-S103. [DOI: 10.1038/modpathol.2015.140] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
48 Amant F, Floquet A, Friedlander M, Kristensen G, Mahner S, Nam EJ, Powell MA, Ray-Coquard I, Siddiqui N, Sykes P, Westermann AM, Seddon B. Gynecologic Cancer InterGroup (GCIG) consensus review for endometrial stromal sarcoma. Int J Gynecol Cancer 2014;24:S67-72. [PMID: 25033257 DOI: 10.1097/IGC.0000000000000205] [Cited by in Crossref: 56] [Cited by in F6Publishing: 60] [Article Influence: 8.0] [Reference Citation Analysis]
49 Hagemann IS, Pfeifer JD, Huettner PC. The uterine corpus. Silverberg's Principles and Practice of Surgical Pathology and Cytopathology 2015. [DOI: 10.1017/9781139137201.039] [Reference Citation Analysis]
50 Lee C, Nucci MR. Endometrial stromal sarcoma - the new genetic paradigm. Histopathology 2015;67:1-19. [DOI: 10.1111/his.12594] [Cited by in Crossref: 75] [Cited by in F6Publishing: 80] [Article Influence: 10.7] [Reference Citation Analysis]
51 Ali RH, Rouzbahman M. Endometrial stromal tumours revisited: an update based on the 2014 WHO classification. J Clin Pathol. 2015;68:325-332. [PMID: 25595274 DOI: 10.1136/jclinpath-2014-202829] [Cited by in Crossref: 73] [Cited by in F6Publishing: 79] [Article Influence: 10.4] [Reference Citation Analysis]
52 Cui Y, Gao D, Linghu E, Zhan Q, Chen R, Brock MV, Herman JG, Guo M. Epigenetic changes and functional study of HOXA11 in human gastric cancer. Epigenomics 2015;7:201-13. [PMID: 25590359 DOI: 10.2217/epi.14.92] [Cited by in Crossref: 29] [Cited by in F6Publishing: 33] [Article Influence: 4.1] [Reference Citation Analysis]
53 Mahadevan P. Pathology of Uterine Sarcomas. Uterine Cancer 2015. [DOI: 10.1007/978-81-322-1892-0_11] [Reference Citation Analysis]
54 Chiang S, Martelotto LG, Weigelt B. Genomic Applications in Gynecologic Malignancies. Genomic Applications in Pathology 2015. [DOI: 10.1007/978-1-4939-0727-4_27] [Reference Citation Analysis]
55 Desouki MM, Fadare O. Gynecologic Tumors. Molecular Oncology Testing for Solid Tumors 2015. [DOI: 10.1007/978-3-319-16304-8_15] [Reference Citation Analysis]
56 Palacios J, Dal Cin P. Molecular Pathology and Cytogenetics of Endometrial Carcinoma, Carcinosarcoma, and Uterine Sarcomas. Current Clinical Oncology 2015. [DOI: 10.1007/7631_2015_6] [Reference Citation Analysis]
57 Tokinaga A, Furuya M, Niino H, Udaka N, Asai-Sato M, Sekido H, Miyagi E. Colonic low-grade endometrial stromal sarcoma and orthotopic endometrial stromal tumor with limited infiltration sharing the JAZF1-SUZ12 gene fusion. Pathol Int 2014;64:178-82. [PMID: 24750188 DOI: 10.1111/pin.12151] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
58 Ali RH, Al-safi R, Al-waheeb S, John B, Al-ali W, Al-jassar W, Al-mulla F, Melnyk N, Huntsman DG, Lee C. Molecular characterization of a population-based series of endometrial stromal sarcomas in Kuwait. Human Pathology 2014;45:2453-62. [DOI: 10.1016/j.humpath.2014.08.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
59 Conklin CM, Longacre TA. Endometrial stromal tumors: the new WHO classification. Adv Anat Pathol 2014;21:383-93. [PMID: 25299308 DOI: 10.1097/PAP.0000000000000046] [Cited by in Crossref: 117] [Cited by in F6Publishing: 126] [Article Influence: 14.6] [Reference Citation Analysis]
60 Sciallis AP, Bedroske PP, Schoolmeester JK, Sukov WR, Keeney GL, Hodge JC, Bell DA. High-grade endometrial stromal sarcomas: a clinicopathologic study of a group of tumors with heterogenous morphologic and genetic features. Am J Surg Pathol 2014;38:1161-72. [PMID: 25133706 DOI: 10.1097/PAS.0000000000000256] [Cited by in Crossref: 64] [Cited by in F6Publishing: 67] [Article Influence: 8.0] [Reference Citation Analysis]
61 Gremel G, Liew M, Hamzei F, Hardell E, Selling J, Ghaderi M, Stemme S, Pontén F, Carlson JW. A prognosis based classification of undifferentiated uterine sarcomas: identification of mitotic index, hormone receptors and YWHAE-FAM22 translocation status as predictors of survival. Int J Cancer 2015;136:1608-18. [PMID: 25130488 DOI: 10.1002/ijc.29141] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.9] [Reference Citation Analysis]
62 Stemme S, Ghaderi M, Carlson JW. Diagnosis of endometrial stromal tumors: a clinicopathologic study of 25 biopsy specimens with identification of problematic areas. Am J Clin Pathol 2014;141:133-9. [PMID: 24343747 DOI: 10.1309/AJCPXD0TPYSNVI8I] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 2.1] [Reference Citation Analysis]
63 Su T, Chao T, Lee H, Perng C, Nieh S. Malignant Potential of Endometrial Stromal Tumor With Limited Infiltration: A Case Report. Int J Surg Pathol 2014;22:559-63. [DOI: 10.1177/1066896913506934] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
64 Tirumani SH, Ojili V, Shanbhogue AK, Fasih N, Ryan JG, Reinhold C. Current concepts in the imaging of uterine sarcoma. Abdom Imaging 2013;38:397-411. [PMID: 22699695 DOI: 10.1007/s00261-012-9919-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
65 Novetsky AP, Powell MA. Management of sarcomas of the uterus. Current Opinion in Oncology 2013;25:546-52. [DOI: 10.1097/cco.0b013e328363e0ef] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
66 Chiang S, Oliva E. Recent developments in uterine mesenchymal neoplasms. Histopathology 2013;62:124-37. [PMID: 23240674 DOI: 10.1111/his.12048] [Cited by in Crossref: 56] [Cited by in F6Publishing: 57] [Article Influence: 6.2] [Reference Citation Analysis]
67 Isphording A, Ali RH, Irving J, Goytain A, Nelnyk N, Hoang LN, Gilks CB, Huntsman DG, Nielsen TO, Nucci MR, Lee C. YWHAE-FAM22 endometrial stromal sarcoma: diagnosis by reverse transcription–polymerase chain reaction in formalin-fixed, paraffin-embedded tumor. Human Pathology 2013;44:837-43. [DOI: 10.1016/j.humpath.2012.08.007] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
68 D’angelo E, Ali RH, Espinosa I, Lee C, Huntsman DG, Gilks B, Prat J. Endometrial Stromal Sarcomas With Sex Cord Differentiation Are Associated With PHF1 Rearrangement. American Journal of Surgical Pathology 2013;37:514-21. [DOI: 10.1097/pas.0b013e318272c612] [Cited by in Crossref: 58] [Cited by in F6Publishing: 42] [Article Influence: 6.4] [Reference Citation Analysis]
69 Brennan MF, Antonescu CR, Maki RG. Other Uterine Sarcomas. Management of Soft Tissue Sarcoma 2013. [DOI: 10.1007/978-1-4614-5004-7_21] [Reference Citation Analysis]
70 Cooley LD, Wilson KS. The Cytogenetics of Solid Tumors. The Principles of Clinical Cytogenetics 2013. [DOI: 10.1007/978-1-4419-1688-4_16] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
71 Brennan MF, Antonescu CR, Maki RG. General Description. Management of Soft Tissue Sarcoma 2013. [DOI: 10.1007/978-1-4614-5004-7_1] [Reference Citation Analysis]
72 Maki RG, Iqbal A. Uterine Sarcomas in the Elderly. Management of Gynecological Cancers in Older Women 2013. [DOI: 10.1007/978-1-4471-4605-6_20] [Reference Citation Analysis]
73 Lazar AJ. Applications of Molecular Testing to Differential Diagnosis. Practical Soft Tissue Pathology: A Diagnostic Approach 2013. [DOI: 10.1016/b978-1-4160-5455-9.00018-1] [Reference Citation Analysis]
74 Lee CH, Ali RH, Rouzbahman M, Marino-Enriquez A, Zhu M, Guo X, Brunner AL, Chiang S, Leung S, Nelnyk N, Huntsman DG, Blake Gilks C, Nielsen TO, Dal Cin P, van de Rijn M, Oliva E, Fletcher JA, Nucci MR. Cyclin D1 as a diagnostic immunomarker for endometrial stromal sarcoma with YWHAE-FAM22 rearrangement. Am J Surg Pathol 2012;36:1562-70. [PMID: 22982899 DOI: 10.1097/PAS.0b013e31825fa931] [Cited by in Crossref: 148] [Cited by in F6Publishing: 153] [Article Influence: 14.8] [Reference Citation Analysis]
75 Jakate K, Azimi F, Ali RH, Lee C, Clarke BA, Rasty G, Shaw PA, Melnyk N, Huntsman DG, Laframboise S, Rouzbahman M. Endometrial sarcomas: an immunohistochemical and JAZF1 re-arrangement study in low-grade and undifferentiated tumors. Mod Pathol 2013;26:95-105. [DOI: 10.1038/modpathol.2012.136] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 3.6] [Reference Citation Analysis]
76 Tropé CG, Abeler VM, Kristensen GB. Diagnosis and treatment of sarcoma of the uterus. A review. Acta Oncol 2012;51:694-705. [PMID: 22793037 DOI: 10.3109/0284186X.2012.689111] [Cited by in Crossref: 105] [Cited by in F6Publishing: 118] [Article Influence: 10.5] [Reference Citation Analysis]
77 Panagopoulos I, Micci F, Thorsen J, Gorunova L, Eibak AM, Bjerkehagen B, Davidson B, Heim S. Novel fusion of MYST/Esa1-associated factor 6 and PHF1 in endometrial stromal sarcoma. PLoS One 2012;7:e39354. [PMID: 22761769 DOI: 10.1371/journal.pone.0039354] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 8.2] [Reference Citation Analysis]
78 Lee C, Mariño-enriquez A, Ou W, Zhu M, Ali RH, Chiang S, Amant F, Gilks CB, van de Rijn M, Oliva E, Debiec-rychter M, Dal Cin P, Fletcher JA, Nucci MR. The Clinicopathologic Features of YWHAE-FAM22 Endometrial Stromal Sarcomas: A Histologically High-grade and Clinically Aggressive Tumor. American Journal of Surgical Pathology 2012;36:641-53. [DOI: 10.1097/pas.0b013e31824a7b1a] [Cited by in Crossref: 208] [Cited by in F6Publishing: 214] [Article Influence: 20.8] [Reference Citation Analysis]
79 Xue W, Cheung AN. Endometrial stromal sarcoma of uterus. Best Practice & Research Clinical Obstetrics & Gynaecology 2011;25:719-32. [DOI: 10.1016/j.bpobgyn.2011.07.004] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
80 Amador-ortiz C, Roma AA, Huettner PC, Becker N, Pfeifer JD. JAZF1 and JJAZ1 gene fusion in primary extrauterine endometrial stromal sarcoma. Human Pathology 2011;42:939-46. [DOI: 10.1016/j.humpath.2010.11.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
81 García-martínez E, Egea Prefasi L, García-donas J, Escolar-pérez PP, Pastor F, González-martín A. Current management of uterine sarcomas. Clin Transl Oncol 2011;13:307-14. [DOI: 10.1007/s12094-011-0659-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
82 Chiang S, Oliva E. Cytogenetic and molecular aberrations in endometrial stromal tumors. Human Pathology 2011;42:609-17. [DOI: 10.1016/j.humpath.2010.12.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
83 Zaloudek CJ. Low-Grade Endometrial Stromal Tumors of the Uterus. Pathology Case Reviews 2011;16:130-138. [DOI: 10.1097/pcr.0b013e31821736c1] [Reference Citation Analysis]
84 Seddon BM, Davda R. Uterine sarcomas--recent progress and future challenges. Eur J Radiol 2011;78:30-40. [PMID: 21247711 DOI: 10.1016/j.ejrad.2010.12.057] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
85 Nucci MR, Quade BJ. Uterine Mesenchymal Tumors. Diagnostic Gynecologic and Obstetric Pathology. Elsevier; 2011. pp. 582-639. [DOI: 10.1016/b978-1-4377-0764-9.00020-2] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
86 Zaloudek CJ, Hendrickson MR, Soslow RA. Mesenchymal Tumors of the Uterus. In: Kurman RJ, Ellenson LH, Ronnett BM, editors. Blaustein’s Pathology of the Female Genital Tract. Boston: Springer US; 2011. pp. 453-527. [DOI: 10.1007/978-1-4419-0489-8_10] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 3.2] [Reference Citation Analysis]
87 Lee S, Song JS, Kim G, Choi J, Kim HK, Lee Y, Kim K. Diagnostic Utility of theJAZF1/JJAZ1Gene Fusion in Endometrial Stromal Sarcomas and Their Histologic Variants. Korean J Pathol 2011;45:498. [DOI: 10.4132/koreanjpathol.2011.45.5.498] [Reference Citation Analysis]
88 Samarnthai N, Hall K, Yeh IT. Molecular profiling of endometrial malignancies. Obstet Gynecol Int 2010;2010:162363. [PMID: 20368795 DOI: 10.1155/2010/162363] [Cited by in Crossref: 76] [Cited by in F6Publishing: 88] [Article Influence: 6.3] [Reference Citation Analysis]
89 Amant F, Coosemans A, Debiec-Rychter M, Timmerman D, Vergote I. Clinical management of uterine sarcomas. Lancet Oncol. 2009;10:1188-1198. [PMID: 19959075 DOI: 10.1016/s1470-2045(09)70226-8] [Cited by in Crossref: 285] [Cited by in F6Publishing: 308] [Article Influence: 23.8] [Reference Citation Analysis]
90 Rabban JT, Soslow RA, Zaloudek CZ. Immunohistology of the Female Genital Tract. Diagnostic Immunohistochemistry. Elsevier; 2010. pp. 690-762. [DOI: 10.1016/b978-1-4160-5766-6.00022-4] [Cited by in Crossref: 8] [Article Influence: 0.7] [Reference Citation Analysis]
91 Oliva E, Baker PM. Endometrial/ioid Stromal Tumors and Related Neoplasms of the Female Genital Tract. Surgical Pathology Clinics 2009;2:679-705. [DOI: 10.1016/j.path.2009.08.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
92 Dal Cin P. Cytogenetics of Mesenchymal Tumors of the Female Genital Tract. Surgical Pathology Clinics 2009;2:813-21. [DOI: 10.1016/j.path.2009.08.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
93 Lee CH, Ali R, Gilks CB. Molecular Genetics of Mesenchymal Tumors of the Female Genital Tract. Surg Pathol Clin 2009;2:823-34. [PMID: 26838781 DOI: 10.1016/j.path.2009.08.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
94 Kurihara S, Oda Y, Ohishi Y, Kaneki E, Kobayashi H, Wake N, Tsuneyoshi M. Coincident expression of β-catenin and cyclin D1 in endometrial stromal tumors and related high-grade sarcomas. Mod Pathol 2010;23:225-34. [DOI: 10.1038/modpathol.2009.162] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 4.1] [Reference Citation Analysis]
95 D'Angelo E, Prat J. Uterine sarcomas: a review. Gynecol Oncol. 2010;116:131-139. [PMID: 19853898 DOI: 10.1016/j.ygyno.2009.09.023] [Cited by in Crossref: 479] [Cited by in F6Publishing: 521] [Article Influence: 36.8] [Reference Citation Analysis]
96 Staats PN, Garcia JJ, Dias-Santagata DC, Kuhlmann G, Stubbs H, McCluggage WG, De Nictolis M, Kommoss F, Soslow RA, Iafrate AJ, Oliva E. Uterine tumors resembling ovarian sex cord tumors (UTROSCT) lack the JAZF1-JJAZ1 translocation frequently seen in endometrial stromal tumors. Am J Surg Pathol 2009;33:1206-12. [PMID: 19542872 DOI: 10.1097/PAS.0b013e3181a7b9cf] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 4.5] [Reference Citation Analysis]
97 Soranzo N, Rivadeneira F, Chinappen-Horsley U, Malkina I, Richards JB, Hammond N, Stolk L, Nica A, Inouye M, Hofman A, Stephens J, Wheeler E, Arp P, Gwilliam R, Jhamai PM, Potter S, Chaney A, Ghori MJ, Ravindrarajah R, Ermakov S, Estrada K, Pols HA, Williams FM, McArdle WL, van Meurs JB, Loos RJ, Dermitzakis ET, Ahmadi KR, Hart DJ, Ouwehand WH, Wareham NJ, Barroso I, Sandhu MS, Strachan DP, Livshits G, Spector TD, Uitterlinden AG, Deloukas P. Meta-analysis of genome-wide scans for human adult stature identifies novel Loci and associations with measures of skeletal frame size. PLoS Genet 2009;5:e1000445. [PMID: 19343178 DOI: 10.1371/journal.pgen.1000445] [Cited by in Crossref: 201] [Cited by in F6Publishing: 212] [Article Influence: 15.5] [Reference Citation Analysis]
98 Oliva E. Pure Mesenchymal and Mixed Müllerian Tumors of the Uterus. Gynecologic Pathology. Elsevier; 2009. pp. 261-329. [DOI: 10.1016/b978-044306920-8.50012-2] [Cited by in Crossref: 5] [Article Influence: 0.4] [Reference Citation Analysis]
99 Mccluggage WG, Robboy SJ. Mesenchymal uterine tumors, other than pure smooth muscle neoplasms, and adenomyosis. Robboy's Pathology of the Female Reproductive Tract. Elsevier; 2009. pp. 427-56. [DOI: 10.1016/b978-0-443-07477-6.50022-6] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
100 Palacios J, Cin PD. Molecular Pathology and Cytogenetics of Endometrial Carcinoma, Carcinosarcoma, and Uterine Sarcomas. Uterine Cancer 2009. [DOI: 10.1007/978-1-60327-044-1_5] [Reference Citation Analysis]
101 Panagopoulos I, Mertens F, Griffin CA. An endometrial stromal sarcoma cell line with the JAZF1/PHF1 chimera. Cancer Genet Cytogenet 2008;185:74-7. [PMID: 18722875 DOI: 10.1016/j.cancergencyto.2008.04.020] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 2.0] [Reference Citation Analysis]
102 Kurihara S, Oda Y, Ohishi Y, Iwasa A, Takahira T, Kaneki E, Kobayashi H, Wake N, Tsuneyoshi M. Endometrial Stromal Sarcomas and Related High-grade Sarcomas: Immunohistochemical and Molecular Genetic Study of 31 Cases. American Journal of Surgical Pathology 2008;32:1228-38. [DOI: 10.1097/pas.0b013e31816a3b42] [Cited by in Crossref: 148] [Cited by in F6Publishing: 152] [Article Influence: 10.6] [Reference Citation Analysis]
103 Kakuno Y, Yamada T, Mori H, Narabayashi I. Establishment and characterization of a cell line (OMC-9) originating from a human endometrial stromal sarcoma. Human Cell 2008;21:46-55. [DOI: 10.1111/j.1749-0774.2008.00050.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
104 Soslow RA. Uterine mesenchymal tumors: a review of selected topics. Diagnostic Histopathology 2008;14:175-88. [DOI: 10.1016/j.mpdhp.2008.02.009] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
105 Parwani A. Molecular Analysis of the JAZF1-JJAZ1 Gene Fusion by RTPCR and Fluorescence In Situ Hybridization in Endometrial Stromal Neoplasms. Yearbook of Pathology and Laboratory Medicine 2008;2008:161-162. [DOI: 10.1016/s1077-9108(08)70632-7] [Reference Citation Analysis]
106 Li H, Ma X, Wang J, Koontz J, Nucci M, Sklar J. Effects of rearrangement and allelic exclusion of JJAZ1/SUZ12 on cell proliferation and survival. Proc Natl Acad Sci U S A 2007;104:20001-6. [PMID: 18077430 DOI: 10.1073/pnas.0709986104] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 4.2] [Reference Citation Analysis]
107 Steinmann K, Cooper DN, Kluwe L, Chuzhanova NA, Senger C, Serra E, Lazaro C, Gilaberte M, Wimmer K, Mautner VF, Kehrer-Sawatzki H. Type 2 NF1 deletions are highly unusual by virtue of the absence of nonallelic homologous recombination hotspots and an apparent preference for female mitotic recombination. Am J Hum Genet 2007;81:1201-20. [PMID: 17999360 DOI: 10.1086/522089] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 3.1] [Reference Citation Analysis]
108 Baker P, Oliva E. Endometrial stromal tumours of the uterus: a practical approach using conventional morphology and ancillary techniques. J Clin Pathol 2007;60:235-43. [PMID: 17347285 DOI: 10.1136/jcp.2005.031203] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 3.7] [Reference Citation Analysis]